Navigation Links
Fingolimod: 'Hint' of advantages in a small group of patients
Date:7/5/2012

This release is available in German.

The immunosuppressive drug fingolimod (trade name: Gilenya) is approved for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in adults. In an early benefit assessment pursuant to "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) assessed whether fingolimod offers an added benefit compared with the present standard therapy.

According to the findings of the assessment, patients with a rapidly progressive and severe course of disease who take fingolimod experience fewer flu-like symptoms. Under consideration of this advantage on the one hand and the uncertain evidence base on the other, IQWIG has concluded that the data provide a "hint" of a minor added benefit of fingolimod for this group of patients.

Due to a lack of evaluable data, an added benefit is not proven for two further groups of patients.

Separate assessment in three groups of patients

According to the different areas of application, IQWiG performed separate assessments of the drug in three groups of patients. Fingolimod was compared with glatiramer acetate in patients with highly active RRMS who had not responded to a complete and appropriate (usually at least one-year) cycle with beta-interferon (IFN-β).

In patients with highly active RRMS who had not received sufficient IFN-β therapy and in those with rapidly progressive severe RRMS, fingolimod was in each case compared with IFN-β 1a.

Evaluable data only for one group of patients

One relevant study was available for the early benefit assessment, an approval study on fingolimod (TRANSFORMS), which compared treatment with fingolimod versus IFN β 1a in adults with RRMS. However, the study only provide
'/>"/>

Contact: Dr. Anna-Sabine Ernst
presse@iqwig.de
49-022-135-6850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study supports urate protection against Parkinsons disease, hints at novel mechanism
2. Early Study Hints at Link Between Certain Sunscreens, Endometriosis
3. Mouse Study Hints at New Path for Diabetes Treatment
4. PawnUp.com Online Pawn Shop Spreads Awareness About its Small Business Loans.
5. Small Babies Can Be Sign of Heart Problems in Mother
6. Smallest, Largest Fetuses at Higher Risk of Stillbirth
7. Standing at Work All Day While Pregnant Linked to Smaller Babies
8. Google Rolls Out Another Panda Algorithm Update – Small Businesses Plan for the Future of SEO
9. B2B e Trader is Addressing the Critical Needs of Local Businesses by Lauching the New Shop Small Business Directory
10. Blood test for pregnant women could predict risk of having dangerously small babies
11. Infants cant distinguish between large and small groups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... group at the DFG Research Center for Regenerative Therapies ... (CRTD) demonstrated for the first time the in vitro ... dimensions from mouse embryonic stem cells. Correct spatial organization ... dorsal/ventral axis was observed., This study has been published ... Reports " on 30.10.2014 ., For many years Elly ...
(Date:10/30/2014)... October 30, 2014 Nutrition Leaders, a ... weight loss aids, and more, is currently hosting a ... is already underway, is open to U.S. residents age ... December 15, 2014. One lucky winner will then be ... a $100 gift card to NutritionLeaders.com. , Nutrition Leaders’ ...
(Date:10/30/2014)... 2014 Graphics, coding, typography and search ... the craft of web design and require thorough knowledge ... simpler solution to create a website can be as ... information, customer reviews and Facebook posts all accumulate on ... the next evolution of how a business can develop ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 High ... exclusive concepts in the medical-grade skin care domain: ... development of uniquely potent topical dermatological products, today ... ( http://www.RefinitySkinScience.com ) with patented COSMEDERM®-7 anti-irritant technology. ... acid concentrations (50% and 70%) and a low ...
(Date:10/30/2014)... PreDiabetes Centers , the pioneer ... shoppers with a supply of sugardown®, a chewable dietary ... blood sugar spikes. Learning how to control blood sugar ... of a diabetes prevention plan. , Shoppers who spend ... tube of sugardown. The offer expires November 30. ...
Breaking Medicine News(10 mins):Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2Health News:Nutrition Leaders Announces Gift Card Sweepstakes 2Health News:Facebook Websites In Thirty-Seconds 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4Health News:PreDiabetes Treatment Company Offers PreD Store Shoppers Supplements to Support Healthy Blood Sugar 2
... , This release is available in German ... in Health Care (IQWiG) has investigated the reliability of diagnosing ... and the benefit that the test results can have for ... According to the report, the available studies do not reveal ...
... detect brain damage in amateur boxers. Deterioration of nerve cells ... This is shown in a new study from the Sahlgrenska ... results of the study conducted by researchers at the Sahlgrenska ... published in the current issue of the scientific journal ...
... shown that patients who receive night home hemodialysis live ... from deceased donors. In a study entitled, ... transplant recipients," published in the international September issue of ... patients were followed for up to 12 years. Night ...
... , , , NEW ORLEANS, Aug. 20 ... the Rouses Market, 4500 Tchoupitoulas Street , Ochsner ... R o uses Markets, the largest independent grocer in Louisiana, will announce ... www.cho o se-healthy.org ." ...
... them individually, study finds , THURSDAY, Aug. 20 (HealthDay ... one nostril detects scents slightly differently than the other, ... in perception result from small differences in the time ... or the other. They call the difference a "binaural" ...
... disorientation occurs quickly without the sun, moon for guidance, , ... losing their way in the wilderness, unwittingly walking in circles ... are true. Without the sun, a compass or a landmark, ... or a desert ended up back where they started, according ...
Cached Medicine News:Health News:Reliability and benefit of diagnostic procedure for asthma in young children is unclear 2Health News:Reliability and benefit of diagnostic procedure for asthma in young children is unclear 3Health News:Reliability and benefit of diagnostic procedure for asthma in young children is unclear 4Health News:Blood test can detect brain damage in amateur boxers 2Health News:Night home hemodialysis shown to be as good as transplant in treating kidney failure 2Health News:Ochsner and Rouses Markets Partner for Choose Healthy Initiative 2Health News:Ochsner and Rouses Markets Partner for Choose Healthy Initiative 3Health News:Nostrils Compete to Relay Key Fragrance 2Health News:Lost Hikers, Backpackers Really Do Walk in Circles 2Health News:Lost Hikers, Backpackers Really Do Walk in Circles 3
(Date:10/30/2014)... 30, 2014  Electronic health records uptake in ... of government initiatives and the considerable resources – ... invested over the past five years. Electronic health ... and U.S. clinicians use them on a daily ... Frost & Sullivan,s newest ...
(Date:10/30/2014)... 2014  Nektar Therapeutics (Nasdaq: NKTR ) ... ended September 30, 2014 on Thursday, November 6, 2014, ... Robin , president and chief executive officer, will host ... 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... audio-only Webcast of the conference call can be accessed ...
(Date:10/30/2014)... 2014  CytRx Corporation (NASDAQ: CYTR ... in oncology, today announced an upcoming presentation highlighting ... aldoxorubicin.  The presentation, titled, "Drug Conjugates Bind Covalently ... by Sant P. Chawla , M.D., F.R.A.C.P., ... investigator of the Company,s ongoing global, pivotal Phase ...
Breaking Medicine Technology:Electronic Health Record Usability: CIOs Weigh In 2Electronic Health Record Usability: CIOs Weigh In 3Electronic Health Record Usability: CIOs Weigh In 4Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 4
Dual offset femoral stems, hip stems that provide unique and competitive features....
Cementless hip stem revisions offering optimal version setting for each patient. Compatible with modular link ceramic or cobalt chromium femoral heads with up to 4 neck lengths, or the link saddle de...
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Medicine Products: